Region:Middle East
Author(s):Geetanshi
Product Code:KRAD7895
Pages:93
Published On:December 2025
The future of the medical cannabis market in Saudi Arabia appears promising, driven by increasing research initiatives and a gradual shift in public perception. As global trends toward cannabis legalization and acceptance continue, local stakeholders are likely to advocate for regulatory reforms. This evolving landscape may lead to enhanced access to cannabinoid therapies, fostering innovation and collaboration within the pharmaceutical sector, ultimately benefiting patients seeking alternative treatment options for chronic conditions.
| Segment | Sub-Segments |
|---|---|
| By Derivatives | Cannabidiol (CBD) Tetrahydrocannabinol (THC) Other Cannabinoids |
| By Application | Cancer Epilepsy Chronic Pain Arthritis Migraine Other Neurological Disorders |
| By Route of Administration | Oral Solutions and Capsules Vaporizers Topicals Other Routes |
| By Species/Formulation | Sativa Indica Hybrid |
| By End-User | Hospitals Clinics Research Institutions Homecare Others |
| By Distribution Channel | Pharmacies Online Retail Direct Sales Others |
| By Geographic Region | Central Region Eastern Region Western Region Southern Region Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Healthcare Professionals | 150 | Doctors, Nurses, Pain Management Specialists |
| Pharmacy Sector | 100 | Pharmacists, Pharmacy Managers |
| Patient Perspectives | 120 | Chronic Pain Patients, Caregivers |
| Regulatory Bodies | 50 | Health Policy Makers, Regulatory Officials |
| Industry Experts | 80 | Market Analysts, Cannabis Industry Consultants |
The Saudi Arabia medical cannabis market is valued at approximately USD 302 million. This valuation reflects the increasing acceptance of cannabis for medical purposes and the government's initiatives to regulate and promote its use.